Medical castration with LHRH agonists is a significant trend in the treatment of locally advanced and metastatic prostate cancer (PC). The article is devoted to the effectiveness of synthetic LHRH agonist buserelin (Buserelin-depo) in the treatment of patients with hormone dependent PC. Administration of Buserelin-depot results in a decrease of the prostate-specific antigen levels. st... https://www.trophywivesri.com/product-category/sodas/